SCHEMBL4435119

SCHEMBL4435119

CC(=O)C(c1ccc(Cl)nc1)c1ccc(F)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 10/20 0.41
KCNQ2 O43526 10/20 0.41
KCNE1 P15382 7/20 0.41
KCNQ1 P51787 7/20 0.41
S1PR3 Q99500 2/20 0.39
BACE1 P56817 1/20 0.36
S1PR2 O95136 1/20 0.35
S1PR1 P21453 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MDM2 Q00987 1/20 0.34
MAPK1 P28482 1/20 0.34
SCN9A Q15858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438585 0.84 S1PR3 (0.42) KCNQ3KCNQ2KCNE1KCNQ1S1PR3
SCHEMBL4440986 0.83 BRD4 (0.46) S1PR3S1PR2S1PR1AKR1C3AKR1C2
SCHEMBL4428091 0.82 P2RX7 (0.38) HDAC3HDAC1HDAC2HDAC6MAPK1
SCHEMBL4434008 0.79 AKR1C3 (0.39) HDAC3HDAC1HDAC2HDAC6AKR1C3
SCHEMBL4440506 0.78 AKR1C3 (0.38) AKR1C3AKR1C2ALDH1A1
SCHEMBL4431036 0.76 KCNQ3 (0.51) KCNQ3KCNQ2KCNE1KCNQ1AKR1C3
SCHEMBL4432365 0.76 AKR1C3 (0.43) AKR1C3AKR1C2ALDH1A1
SCHEMBL4432457 0.76 NPC1 (0.39) KCNQ3KCNQ2S1PR3S1PR1HDAC3
SCHEMBL4431484 0.76 APLNR (0.38) S1PR3S1PR2S1PR1HDAC3HDAC1
SCHEMBL4433750 0.75 HDAC4 (0.35) HDAC3HDAC1HDAC2HDAC6AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed